Nephros Inc (NEPH) company profile

Nephros, Inc. develops and commercializes point-of-use water filtration products for medical and commercial applications. The company operates two medical filtration product lines: infection control microfilters and ultrafilters that remove bacteria, viruses, and endotoxins, and dialysis ultrafilters that purify water and bicarbonate concentrates used in hemodialysis treatments. Its commercial offerings feature carbon-based and carbon-free filters designed to eliminate taste, odor, lead, cysts, scale, and per- and polyfluoroalkyl substances. Nephros primarily serves hospitals, healthcare facilities, dialysis clinics, and foodservice and hospitality establishments, alongside laboratories, manufacturing plants, aviation environments, and government facilities.

The company markets its products in the United States and international markets using an internal direct sales force and distributors, including value-added resellers. It maintains an office in Whippany, New Jersey, and operates a commercial filter manufacturing site alongside its corporate headquarters in South Orange, New Jersey. Medical filtration products are sourced through an exclusive supply partner located in Italy.

Summary of the business section of Nephros's latest annual report, written by StockData.

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

“of December 31, 2025, we employed a total of 36 full-time employees, including 12 employed in sales/marketing/customer support, 17 in”